分支链氨基酸和患重度抑郁症的风险:一种门德尔的随机化和局部化研究
Xiang Li1,2,3, Jianyi Wang4
1Medical College, Guangxi University, Nanning, China.
Psychopharmacology
|July 15, 2025
概括
抑郁症可能会增加氨酸水平,这表明存在因果关系. 在这项遗传研究中,其他分支链氨基酸 (BCAA) 与抑郁风险没有显著的关联.
科学领域:
- 代谢途径 代谢途径
- 精神病学遗传学 精神病学遗传学
- 生物化学 生物化学
背景情况:
- 抑郁症与代谢异常有关.
- 以前的研究表明抑郁症与分支链氨基酸 (BCAA) 代谢之间存在联系,但因果关系尚不清楚.
研究的目的:
- 调查抑郁风险与BCAA水平之间的因果关系.
- 使用两个样本的门德尔随机化 (MR) 分析来探索遗传因果关系.
主要方法:
- 从IEU OpenGWAS中提取了BCAA的单核酸多态 (SNP).
- 从精神病基因组学联盟获得了主要抑郁症 (MDD) 数据.
- 在欧洲人口GWAS数据上进行了MR分析,链接不平衡得分回归和同地化分析.
主要成果:
- 患MDD的风险对增加氨酸水平有因果关系 (OR=1.043,P=0.024).
- 在MDD和瓦林之间发现了显著的遗传相关性 (r=0.112,P=0.002).
- 没有观察到白素,单素或总BCAA与MDD风险的因果关系.
结论:
- 抑郁症可能会因果地影响瓦林代谢.
- 其他BCAA与抑郁症之间没有发现显著的遗传联系.
- 这些发现为抑郁症的代谢基础提供了新的见解.
相关概念视频
Human Genetics
732
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
732
Depressive Disorders: Etiology
172
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
172
Antidepressant Drugs: MAOIs and Other Agents
372
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
372
Depressive Disorders: MDD and Dysthymia
222
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
222
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Biological Causes of Schizophrenia
151
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
151


